Get the tools used by (smart)2 investors.

Capital Expenditures Forecast (FINBOX) for Amphastar P

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

AMPH: Amphastar P

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, ...

24.19 USD
Price
USD
Fair Value
Upside
22.64 - 53.95
52-week range

Analysis

How does Amphastar P's Capital Expenditures Forecast (FINBOX) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Amphastar P because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Capital Expenditures Forecast

Hide this widget
capex_proj
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Capital Expenditures Forecast (FINBOX) in the forecast category include:

View Full List

Search for metric or datapoint

Capital Expenditures Forecast

Projected capital expenditures.

Definition of Capital Expenditures Forecast (FINBOX)

Sector Benchmark Analysis

All rights reserved. Terms Of Use